Portfolio company
CroiValve
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops a transcatheter heart valve system to treat tricuspid regurgitation in patients unsuitable for open-heart surgery.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CroíValve
The company develops a minimally invasive transcatheter valve system to treat tricuspid regurgitation for elderly and frail cardiac patients.
TRiCares
This company develops a catheter-based tricuspid valve replacement system for patients suffering from tricuspid regurgitation.
Valcare Medical
The company develops transcatheter repair and replacement technologies for heart valves to treat patients with mitral and tricuspid regurgitation.
Coramaze
This medical technology company develops a transcatheter valve repair system for treating patients with tricuspid regurgitation and other structural heart conditions.
TRICUSPID VALVE REPAIR
Versa Vascular develops a transcatheter tricuspid valve repair system for patients suffering from tricuspid regurgitation to restore heart function without requiring open-heart surgery.
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
CoreValve SA
This company develops trans-catheter aortic valve replacement systems for patients with severe aortic stenosis who are unsuitable for open-heart surgery.
JenaValve
This medical device company develops transcatheter heart valve replacement systems for patients suffering from symptomatic aortic regurgitation and aortic stenosis.